Events - Page 3
Should you feel bad every time you turn off your laptop?
Hvordan prioritere innenfor behandling og kreftforskning?
The leading conference for life sciences gather the actors who will develop a world-leading health industry in Norway.
In this meeting we will address the major trends in clinical trials and discuss if this is an opportunity or a barrier for Norway to be competitive in attracting more clinical trials.
The leading conference for life sciences gather the actors who will develop a world-leading health industry in Norway.
To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.
Welcome to a lecture organized by SPARK Norway and Nansen Neuroscience Network.
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Professor Ewan Birney will give a public talk and guest lecture at the Radium Hospital in Oslo.
How can academic discoveries be advanced to a commercial setting more efficiently? How can the university – industry bridge be strengthened and how can investors engage to advance the growing portfolio of investment opportunities emerging from the Nordic SPARK initiative?
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Welcome to our dScience lunch seminar in the Science Library! This event is open to everyone.
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Dr. Marta Melé, group leader at the Barcelona Supercomputing Centre, Spain, will present her research on "The anatomy of expression and alternative splicing variation across human traits."
SPARK Europe Educational Forum are monthly open meetings hosted by UiO:Life Science and SPARK Europe partners.
Dr. Renée Beekman, Group Leader at the Centre for Genomic Regulation, Barcelona, Spain, will present her lecture "Understanding early lymphoma formation from a single-cell epigenomics and 3D chromatin perspective."
Dr. Bart Deplancke, Professor at the ?cole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, will present his lecture "Resolving the molecular mechanisms underlying regulatory variation-mediated phenotypic diversity."
UiO:Life Sciences' first generation of convergence environments started up in 2017. Their research period is about to finish. Welcome to join us celebrating their achievements.
SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
From the end of February, the new innovation unit at the University of Oslo – the Life Science Growth House – will be an open door for researchers and students who need help to mature ideas at an early stage; leaders and administrative employees who support the innovative researchers; and existing and new external collaborators. At this launch seminar we gather the whole innovation ecosystem in life sciences in Oslo.
Plants have been used for thousands of years in the treatment of human diseases. With over 390,000 known plant species, how do we identify which plants are potential sources for novel pharmaceuticals?
Dr. Fran Supek, Group Leader at the Institute for Research in Biomedicine, Barcelona, Spain, will present his work on "Mutation clusters in cancer genomes: causes, consequences and opportunities."
In the autumn of 2021, the method for organ donation called cDCD (controlled donation after circulatory death) was approved in Norway after a long and thorough process. In this process, critical questions were asked although the method is already established in many other countries. In order to maintain good trust in the health care system, we want to address this questions surrounding organ donation after cardiac arrest, and provide some insights into how cDCD is performed in practice: How is the dying patient and relatives taken into account? What exactly is cDCD?